|
1
|
Malek SN: The biology and clinical
significance of acquired genomic copy number aberrations and
recurrent gene mutations in chronic lymphocytic leukemia. Oncogene.
32:2805–2817. 2013. View Article : Google Scholar :
|
|
2
|
Zhu DX, Zhu W, Fang C, Fan L, Zou ZJ, Wang
YH, Liu P, Hong M, Miao KR, Liu P, et al: miR-181a/b significantly
enhances drug sensitivity in chronic lymphocytic leukemia cells via
targeting multiple anti-apoptosis genes. Carcinogenesis.
33:1294–1301. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bianchi S, Dighiero G and Pritsch O:
Selected topics in chronic lymphocytic leukemia pathogenesis.
Chronic Lymphocytic Leukemia. InTech; Rijeka: pp. 3–18. 2012
|
|
4
|
Wójtowicz M and Wołowiec D: Dysregulation
of apoptosis and proliferation in CLL cells. Chronic Lymphocytic
Leukemia. InTech; Rijeka: pp. 37–62. 2012
|
|
5
|
Wang P, Pavletic ZS and Joshi SS:
Increased apoptosis in B-chronic lymphocytic leukemia cells as a
result of cyclin D3 down regulation. Leuk Lymphoma. 43:1827–1835.
2002. View Article : Google Scholar
|
|
6
|
Razavi R, Gehrke I, Gandhirajan RK,
Poll-Wolbeck SJ, Hallek M and Kreuzer KA: Nitric oxide-donating
acetylsalicylic acid induces apoptosis in chronic lymphocytic
leukemia cells and shows strong antitumor efficacy in vivo. Clin
Cancer Res. 17:286–293. 2011. View Article : Google Scholar
|
|
7
|
Halina A, Artur P, Barbara MK, Joanna S
and Anna D: Alterations in TP53, cyclin D2, c-Myc, p21WAF1/CIP1 and
p27KIP1 expression associated with progression in B-CLL. Folia
Histochem Cytobiol. 48:534–541. 2010.
|
|
8
|
Decker T, Hipp S, Ringshausen I, Bogner C,
Oelsner M, Schneller F and Peschel C: Rapamycin-induced G1 arrest
in cycling B-CLL cells is associated with reduced expression of
cyclin D3, cyclin E, cyclin A, and survivin. Blood. 101:278–285.
2003. View Article : Google Scholar
|
|
9
|
Decker T, Schneller F, Hipp S, Miething C,
Jahn T, Duyster J and Peschel C: Cell cycle progression of chronic
lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3,
cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Leukemia. 16:327–334. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Damle RN, Calissano C and Chiorazzi N:
Chronic lymphocytic leukaemia: A disease of activated monoclonal B
cells. Best Pract Res Clin Haematol. 23:33–45. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sainz-Perez A, Gary-Gouy H, Gaudin F,
Maarof G, Marfaing-Koka A, de Revel T and Dalloul A: IL-24 induces
apoptosis of chronic lymphocytic leukemia B cells engaged into the
cell cycle through dephosphorylation of STAT3 and stabilization of
p53 expression. J Immunol. 181:6051–6060. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Caligaris-Cappio F and Ghia P: Novel
insights in chronic lymphocytic leukemia: Are we getting closer to
understanding the pathogenesis of the disease? J Clin Oncol.
26:4497–4503. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Soma LA, Craig FE and Swerdlow SH: The
proliferation center microenvironment and prognostic markers in
chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum
Pathol. 37:152–159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schwechheimer C and Deng XW: The
COP/DET/FUS proteins-regulators of eukaryotic growth and
development. Semin Cell Dev Biol. 11:495–503. 2000. View Article : Google Scholar
|
|
15
|
Yi C, Wang H, Wei N and Deng XW: An
initial biochemical and cell biological characterization of the
mammalian homologue of a central plant developmental switch, COP1.
BMC Cell Biol. 3:302002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yi C and Deng XW: COP1 - from plant
photomorphogenesis to mammalian tumorigenesis. Trends Cell Biol.
15:618–625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marine JC: Spotlight on the role of COP1
in tumorigenesis. Nat Rev Cancer. 12:455–464. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei W and Kaelin WG Jr: Good COP1 or bad
COP1? In vivo veritas. J Clin Invest. 121:1263–1265. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wertz IE, O'Rourke KM, Zhang Z, Dornan D,
Arnott D, Deshaies RJ and Dixit VM: Human De-etiolated-1 regulates
c-Jun by assembling a CUL4A ubiquitin ligase. Science.
303:1371–1374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dornan D, Wertz I, Shimizu H, Arnott D,
Frantz GD, Dowd P, O'Rourke K, Koeppen H and Dixit VM: The
ubiquitin ligase COP1 is a critical negative regulator of p53.
Nature. 429:86–92. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vitari AC, Leong KG, Newton K, Yee C,
O'Rourke K, Liu J, Phu L, Vij R, Ferrando R, Couto SS, et al: COP1
is a tumour suppressor that causes degradation of ETS transcription
factors. Nature. 474:403–406. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qi L, Heredia JE, Altarejos JY, Screaton
R, Goebel N, Niessen S, Macleod IX, Liew CW, Kulkarni RN, Bain J,
et al: TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism.
Science. 312:1763–1766. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dentin R, Liu Y, Koo SH, Hedrick S, Vargas
T, Heredia J, Yates J III and Montminy M: Insulin modulates
gluconeogenesis by inhibition of the coactivator TORC2. Nature.
449:366–369. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kato S, Ding J, Pisck E, Jhala US and Du
K: COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate
FoxO1-mediated gene expression. J Biol Chem. 283:35464–35473. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dornan D, Bheddah S, Newton K, Ince W,
Frantz GD, Dowd P, Koeppen H, Dixit VM and French DM: COP1, the
negative regulator of p53, is overexpressed in breast and ovarian
adeno-carcinomas. Cancer Res. 64:7226–7230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee YH, Andersen JB, Song HT, Judge AD,
Seo D, Ishikawa T, Marquardt JU, Kitade M, Durkin ME, Raggi C, et
al: Definition of ubiquitination modulator COP1 as a novel
therapeutic target in human hepatocellular carcinoma. Cancer Res.
70:8264–8269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li YF, Wang DD, Zhao BW, Wang W, Huang CY,
Chen YM, Zheng Y, Keshari RP, Xia JC and Zhou ZW: High level of
COP1 expression is associated with poor prognosis in primary
gastric cancer. Int J Biol Sci. 8:1168–1177. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yoshida A, Kato JY, Nakamae I and
Yoneda-Kato N: COP1 targets C/EBPα for degradation and induces
acute myeloid leukemia via Trib1. Blood. 122:1750–1760. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Migliorini D, Bogaerts S, Defever D, Vyas
R, Denecker G, Radaelli E, Zwolinska A, Depaepe V, Hochepied T,
Skarnes WC, et al: Cop1 constitutively regulates c-Jun protein
stability and functions as a tumor suppressor in mice. J Clin
Invest. 121:1329–1343. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rosén A, Bergh AC, Gogok P, Evaldsson C,
Myhrinder AL, Hellqvist E, Rasul A, Björkholm M, Jansson M,
Mansouri L, et al: Lymphoblastoid cell line with B1 cell
characteristics established from a chronic lymphocytic leukemia
clone by in vitro EBV infection. Oncoimmunology. 1:18–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pekarsky Y, Zanesi N and Croce CM:
Molecular basis of CLL. Semin Cancer Biol. 20:370–376. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wolowiec D, Wojtowicz M, Ciszak L,
Kosmaczewska A, Frydecka I, Potoczek S, Urbaniak-Kujda D,
Kapelko-Slowik K and Kuliczkowski K: High intracellular content of
cyclin-dependent kinase inhibitor p27Kip1 in early- and
intermediate stage B-cell chronic lymphocytic leukemia lymphocytes
predicts rapid progression of the disease. Eur J Haematol.
82:260–266. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Giné E, Martinez A, Villamor N,
López-Guillermo A, Camos M, Martinez D, Esteve J, Calvo X,
Muntañola A, Abrisqueta P, et al: Expanded and highly active
proliferation centers identify a histological subtype of chronic
lymphocytic leukemia (accelerated chronic lymphocytic leukemia)
with aggressive clinical behavior. Haematologica. 95:1526–1533.
2010. View Article : Google Scholar
|
|
34
|
Huang H and Tindall DJ: Dynamic FoxO
transcription factors. J Cell Sci. 120:2479–2487. 2007. View Article : Google Scholar : PubMed/NCBI
|
